
Acta Crystallographica, Section C: Crystal Structure Communications p. 2030 - 2032 (1999)
Update date:2022-08-04
Topics:
Neels, Antonia
Stoeckli-Evans, Helen
Plasseraud, Laurent
Garcia Fidalgo, Eva
Suess-Fink, Georg
The homologous title molecules, [Ru2Br4(C10H14) 2]·-C6H6, (1), and [Ru2I4(C10H14) 2]·C7H8, (2), consist of arene-ruthenium moieties [Ru-to-ring distances of 1.655 (2) A in (1) and 1.673 (3) A in (2)] with a terminal halogen ligand [Ru - Br 2.548 (1) A in (1) and Ru - I 2.726 (1) A in (2)], held together by two symmetrical halogen bridges [Ru - Br 2.575 (1) A in (1) and Ru - I 2.736 (1) A in (2)]. The arene rings are planar and parallel to each other, and the terminal halogen ligands are coordinated to ruthenium trans with respect to each other. Both molecules possess Ci symmetry.
Purestar Chem Enterprise Co.,Ltd
website:http://www.purestarchem.com
Contact:05722157374
Address:no235.huanchengdong Rd
Shandong Jiading Chemical Co.,ltd
Contact:18325433111 15964061721
Address:shandong zouping
SEA BRGIHT INDUSTRY CO.,LIMITED
Contact:0086 755 8622 3990
Address:Rm 17B3,GuangCaiXinTianDi Bldg,GuiMiao Rd,NanShan District,Shenzhen,China
Hangzhou Hysen Pharma co.,Ltd.
website:http://www.hysenpharma.cn/
Contact:0086-571-88298791
Address:#701,Gudun Road Hangzhou
HANGZHOU FOREWIN PHARMA CO., LTD
Contact:+86-571-89053961
Address:hangzhou
Doi:10.1039/c29710001506
(1971)Doi:10.1055/s-1999-3174
(1999)Doi:10.1021/ic990631y
(2000)Doi:10.1016/S0277-5387(99)00300-9
(1999)Doi:10.1248/cpb.52.1105
(2004)Doi:10.1002/(SICI)1522-2675(19991215)82:12<2260::AID-HLCA2260>3.0.CO;2-Z
(1999)